Comparing LPS Detection Methods: LAL, rFC, and MAT Assays

What Is LPS and Why Detection Matters

Endotoxin is lipopolysaccharide (LPS) from the outer membrane of Gram-negative bacteria. It is heat stable, and autoclaving does not destroy it,¹ and many products labeled sterile may not be endotoxin-free.²

In the lab, endotoxin can interfere with common in vitro work such as cell culture and transfection.² If a peptide carries it, an effect in a cell-based assay may come from the contaminant rather than the peptide. Endotoxin testing can give a quantitative result in endotoxin units (EU) per mL or per mg, or a pass/fail result against a stated limit; for how those numbers are set and read, see LPS detection sensitivity and EU/mL specifications.

Overview of LPS Detection Methods

The main methods fall into two groups: enzyme tests built on the horseshoe crab clotting pathway (LAL, rFC, and recombinant cascade reagents) and the cell-based monocyte activation test. The enzyme tests are built for endotoxin detection; MAT responds to anything that triggers the cells’ pyrogenic (fever-causing) signal, including non-endotoxin pyrogens.^{3, 4}

A fourth method, the rabbit pyrogen test, is being phased out, most completely in Europe. The European Pharmacopoeia (Ph. Eur.) removed it from 57 texts and added general chapter 5.1.13 on pyrogenicity, with implementation on 1 July 2025.⁵ In the United States, FDA has accepted an LAL test for endotoxins in place of the rabbit test for more than 30 years, although some USP monographs still name the rabbit test.⁶

Where the Pharmacopeias Stand in 2026

These chapters are written for pharmaceutical manufacturing; for research materials they serve as reference methods for what a well-run endotoxin test looks like.

Limulus Amebocyte Lysate (LAL) Assays

The LAL assay detects endotoxin with a clotting cascade taken from horseshoe crab blood cells (amebocytes). LPS activates Factor C, which activates Factor B; Factor B converts the proclotting enzyme into the clotting enzyme, which cuts a protein called coagulogen into an insoluble gel.¹² Because each step amplifies the one before, the test can respond to picogram to nanogram amounts of endotoxin.¹²

The LAL test comes in three formats. Gel-clot is a qualitative limit test (clot or no clot), while turbidimetric and chromogenic methods are quantitative, reading cloudiness or color.^{2, 7} Kinetic versions read the signal over time; for the plate-reader approach, see kinetic chromogenic LAL for real-time LPS monitoring.

LAL’s main specificity weakness is a second trigger: (1→3)-β-D-glucan activates a separate enzyme, Factor G, which feeds into the same clotting step, so a standard LAL assay reacts to glucans as well as endotoxin.¹² Endotoxin-specific LAL reagents suppress that branch, for example by adding excess β-glucan.¹³

Recombinant Factor C (rFC) Assays

The rFC assay uses a recombinant (lab-made) version of Factor C, the first enzyme in the LAL cascade. Endotoxin binding activates it, and the active enzyme cuts a synthetic substrate that releases a fluorescent signal in a single step.¹⁴ With no Factor G present, the rFC assay does not react with glucans, which reduces false positives;¹⁴ one commercial kit reports a linear range of 0.005 to 5.0 EU/mL.¹⁴

A related option, the recombinant cascade reagent (rCR), rebuilds three factors of the LAL cascade and reads out by kinetic color change instead of fluorescence. Both rFC and rCR are covered by USP <86>.^{15, 16}

Sustainability drives much of the interest: the EDQM describes rFC as a step toward easing reliance on horseshoe crabs for lysate,⁸ and Charles River has estimated about 70 million LAL tests a year.¹⁵ Recombinant reagents are not always a drop-in swap: some need longer incubation, have a narrower range, or need extra validation.²

How Recombinant Factor C Compares With LAL in Studies

In a 2014 to 2019 proficiency program with 13 unknown samples, two rFC assays gave results comparable to kinetic chromogenic LAL; mean sample recovery was 120% for LAL and 107% and 100% for the rFC methods, all within the 50% to 200% acceptance range.¹⁷ In a study of 30 biopharmaceutical products, rFC showed more interference than LAL for some of the products tested but overcame it with extra dilution, and two rFC reagents from different makers needed different dilutions for some samples.¹⁸

Monocyte Activation Test (MAT)

The monocyte activation test measures a biological response rather than an enzyme reaction. It uses donated blood cells (monocytes) or a monocytic cell line to model the pyrogenic response: the cells are incubated with the sample, and the cytokines they release, commonly interleukin-6 (IL-6), are measured by ELISA (a plate-based antibody test).^{3, 19}

Because it reads the cells’ response, the MAT assay detects both endotoxin and non-endotoxin pyrogens.^{3, 4}

For when a pyrogen test is needed instead of an endotoxin test, see pyrogen testing vs endotoxin testing for peptides.

LAL vs rFC vs MAT: Key Differences at a Glance

LAL and rFC both measure endotoxin through Factor C, while MAT measures a cell response to any pyrogen. The table sets out the main differences.

Which LPS Detection Method Is Most Specific?

For endotoxin specifically, the rFC assay is generally regarded as the more specific option, because it contains only the endotoxin-sensing enzyme and none of the other horseshoe crab blood components.^{14, 17} Endotoxin-specific LAL reagents narrow the gap by blocking the glucan pathway.¹³ MAT is the least specific for endotoxin by design: its strength is breadth. In one study of different LPS structures, only the rFC assay showed a significant positive correlation with IL-6 release from a monocytic cell line.¹⁹

Interference and Masking Challenges in LPS Detection

Sample components can make any of these methods read too low or too high. Endotoxin masking, also called low endotoxin recovery (LER), happens when surfactants and buffers in a formulation disrupt endotoxin aggregates so the test recovers less than is present; it depends on time and temperature, and regulators expect hold-time studies.²⁰

Masked endotoxin is not inert: undetected endotoxin can still trigger responses in cell-based assays.²⁰ Labs check for interference by spiking a known amount of endotoxin into the sample (a positive product control) and accepting recoveries of 50% to 200% (photometric methods, per USP <85>),²¹ and FDA recommends finding the lowest dilution that overcomes interference.⁶ A cell-based method is sometimes considered as a cross-check. For causes, controls, and fixes, see endotoxin masking and interference in peptide samples.

Choosing the Right LPS Detection Method for Research Use

Choose the method from the question you need answered and the sample you have. For a routine endotoxin number on a simple aqueous sample, an LAL assay or rFC assay is usually enough; MAT earns its place when non-endotoxin pyrogens or masking are real concerns.

The main factors are the sample matrix (detergents, chelators, glucan sources such as cellulose materials), the sensitivity you need, specificity, equipment (a fluorescence reader for rFC, cell culture for MAT), sustainability policy, and whether results must match a pharmacopeial method or a supplier report.

When to Use Which Assay (Checklist)

• Quick pass/fail against a limit, minimal equipment: gel-clot LAL.
• Quantitative endotoxin result on a plate reader: kinetic turbidimetric or chromogenic LAL, or rFC.
• Possible glucans in the sample: rFC or an endotoxin-specific LAL reagent.
• Animal-free reagent preferred: rFC or a recombinant cascade reagent.
• Concern about non-endotoxin pyrogens: add MAT as a complement.
• Poor spike recovery or suspected masking: fix interference first, then consider a second method.
• Comparing with a supplier’s report: use the same method family or document why results may differ.

Why No Single LPS Detection Method Fits Every Use Case

No single method fits every case because each one measures a different thing. LAL and rFC measure endotoxin through an enzyme reaction; MAT measures a cell response. A sample can pass one and not the other for good reasons.

FDA asks firms to assess the risk of non-endotoxin pyrogens rather than assume an endotoxin test covers them.⁶ Pairing methods (an orthogonal approach) can cover these gaps when the stakes justify the cost.

Understanding LPS Detection Methods Supports Better Research Outcomes

Knowing which method produced an endotoxin result tells you what the number covers and what it might miss. When reading supplier documentation, look for the result, method and reagent type, acceptance limit, and appropriate assay-validity checks. A suitable gel-clot limit test can legitimately report pass/fail rather than an exact EU value; your own handling after receipt still decides what reaches the assay.

Frequently asked questions

All peptides discussed here are for research use only.

Key Takeaways

• LPS detection measures bacterial endotoxin; LAL, rFC, and MAT are the main methods.
• LAL and rFC both work through Factor C; rFC avoids the glucan pathway and horseshoe crab lysate.
• MAT measures a cell cytokine response, so it detects non-endotoxin pyrogens as well as endotoxin.
• Ph. Eur. removed the rabbit pyrogen test from 57 texts from July 2025, and USP <86> made recombinant reagents official in May 2025.
• Masking can hide endotoxin, so check spike recovery and match the method to the sample.

References

1. Magalhães PO, Lopes AM, Mazzola PG, Rangel-Yagui C, Penna TCV, Pessoa A Jr. Methods of endotoxin removal from biological preparations: a review. Journal of Pharmacy and Pharmaceutical Sciences. 2007;10(3):388-404. J Pharm Pharm Sci
2. D’Amico D. Endotoxins 101: Guide to Bacterial Endotoxin / LAL Testing. Thermo Fisher Scientific, Life in the Lab, September 2024. thermofisher.com
3. Lonza Bioscience. PyroCell Monocyte Activation Test (MAT) kit (product information: cryopreserved pooled PBMC, IL-6 ELISA readout, Ph. Eur. 2.6.30). bioscience.lonza.com
4. Hasiwa N, Daneshian M, Bruegger P, et al. Evidence for the detection of non-endotoxin pyrogens by the whole blood monocyte activation test. ALTEX. 2013;30(2):169-208. altex.org
5. EDQM. Ph. Eur. bids adieu to rabbit pyrogen test in its monographs. Press release, July 2024. edqm.eu
6. US Food and Drug Administration. Pyrogen and Endotoxins Testing: Questions and Answers (Edition 2). Guidance for industry, March 2026. fda.gov
7. US Food and Drug Administration / ICH. Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions, Annex 14: Bacterial Endotoxins Test General Chapter. Guidance for industry, October 2013. fda.gov
8. European Directorate for the Quality of Medicines & HealthCare (EDQM). Recombinant factor C: new Ph. Eur. chapter available as of 1 July 2020 (general chapter 2.6.32, effective 1 January 2021). edqm.eu
9. United States Pharmacopeia. Notice: General Chapter <86> Bacterial Endotoxins Test Using Recombinant Reagents (official May 2025). July 2024. usp.org
10. United States Pharmacopeia. Chapter for endotoxin testing using non-animal derived reagents published for early adoption. November 1, 2024. usp.org
11. EDQM. Replacement, Reduction and Refinement of animal testing (3Rs): latest achievements (Ph. Eur. Commission decisions on the rabbit pyrogen test and general chapter 2.6.30). edqm.eu
12. Iwanaga S. Biochemical principle of Limulus test for detecting bacterial endotoxins. Proceedings of the Japan Academy, Series B. 2007;83(4):110-119. PMC3756735
13. FUJIFILM Wako Pure Chemical Corporation. Endotoxin-specific LAL. Wako Blog, April 2021. labchem-wako.fujifilm.com
14. Lonza Bioscience. PyroGene Recombinant Factor C Endpoint Fluorescent Assay (product information). bioscience.lonza.com
15. Charles River Laboratories. Recombinant Factor C Assay: Under the Microscope. Eureka blog, January 2023. criver.com
16. Charles River Laboratories. The Road to Regulatory Approval for Recombinant Cascade Reagents: USP Approves Chapter <86>. Insights, August 2024. criver.com
17. Piehler M, Roeder R, Blessing S, Reich J. Comparison of LAL and rFC assays: participation in a proficiency test program between 2014 and 2019. Microorganisms. 2020;8(3):418. mdpi.com
18. Kang DH, Yun SY, Eum S, et al. A study on the application of recombinant factor C (rFC) assay using biopharmaceuticals. Microorganisms. 2024;12(3):516. mdpi.com
19. Abate W, et al. Evaluation of recombinant factor C assay for the detection of divergent lipopolysaccharide structural species and comparison with Limulus amebocyte lysate-based assays and a human monocyte activity assay. Journal of Medical Microbiology. 2017;66(7):888-897. microbiologyresearch.org
20. bioMérieux. Low Endotoxin Recovery: A Comprehensive Overview. Scientific library. biomerieux.com
21. United States Pharmacopeia. General Chapter <85> Bacterial Endotoxins Test. USP-NF. uspnf.com